-
Evaluating the Cost-Benefit of Automated Dispensing Cabinets in Long-Term Care and Closed-Door Pharmacies
Mar 10, 2025, 14:00 PM -
Economic Burden of Opioid-Induced Constipation Among Patients With or Without Cancer in the United States
Mar 10, 2025, 14:00 PM -
Comparative Risk of Major Adverse Cardiovascular Events among Patients who Initiate Treatment with Acute Migraine Agents
Mar 10, 2025, 14:00 PM -
Real-World Adjuvant Nivolumab Utilization in Surgically Treated Muscle-Invasive Bladder Cancer Patients within U.S. Community Oncology Practice
Mar 10, 2025, 14:00 PM -
Benchmarking Disease Prevalence in a Large Scale Electronic Health Record Data Network: An Assessment of Chronic and Rare Disease in the United States in 2023
Mar 10, 2025, 14:00 PM -
Population Impact Model of Faricimab and Aflibercept 8mg among US patients with Diabetic Macular Edema and Neovascular Age-Related Macular Degeneration
Mar 10, 2025, 14:00 PM -
Association Between Vaginal Progesterone Use and Risk of Preterm Birth Among High-Risk Pregnancies: A Real-World Evidence Study
Mar 10, 2025, 14:00 PM -
Real-world Clinical And Demographic Characteristics Associated With Progression To Type 2 Diabetes In Patients With Prediabetes
Mar 10, 2025, 14:00 PM -
The Cost of 340B to States
Mar 10, 2025, 14:00 PM -
Cost-Effectiveness Analysis of Technological Innovation for Chronic Wounds: Pharmacoeconomic Model Based on LOGIT and MAIC Tools
Mar 10, 2025, 14:00 PM -
Identifying Treatment Patterns for Essential Thrombocythemia Using Real-world Data
Mar 10, 2025, 14:00 PM -
Advancing Real World Evidence: Comparative Insights into Global Practices and China's Strategic Progress
Mar 10, 2025, 14:00 PM -
Are Commercial Insurance Premiums Associated With the 340B Drug Pricing Program?
Mar 10, 2025, 14:00 PM -
Real-World Utilization and Predictors of Neurohormonal Inhibitors Use in Young and Middle-Aged Breast Cancer Patients, Initiating Anthracycline-Based Treatments
Mar 10, 2025, 14:00 PM -
Patient Optimism and the Trade-Off Between Kidney Quality and Waiting Time
Mar 10, 2025, 14:00 PM -
Symptom Burden of Acute Influenza Infection Among US Adults: An Interim Analysis of a Nationwide Prospective Study
Mar 10, 2025, 14:00 PM -
Variability in Definitions and Measurement Approaches of Vaso-Occlusive Crises (VOCs) in Sickle Cell Disease (SCD): A Targeted Literature Review of Global Real-World Evidence (RWE) Studies
Mar 10, 2025, 14:00 PM -
Impact of NICE Severity Modifiers on Willingness-to-Pay Thresholds
Mar 10, 2025, 14:00 PM -
Population-Level Impact of Emicizumab for Hemophilia A Patients in Six Latin American (LATAM) Countries: A 25-Year Model
Mar 10, 2025, 14:00 PM -
Health-Related Quality of Life and Associated Factors Among Patients With Chronic Diseases in Hainan Province, China
Mar 10, 2025, 14:00 PM